FY2025 · period end Dec '25 · from the 10-K filed Feb 27, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $4.53B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001175454-26-000040 | May 21, 2026 | May 22, 2026 | May 22, 2026 20:15 UTC | EDGAR |
| 8-K | 0001175454-26-000034 | May 7, 2026 | May 12, 2026 | May 12, 2026 20:15 UTC | EDGAR |
| 8-K | 0001175454-26-000036 | May 12, 2026 | May 12, 2026 | May 12, 2026 21:01 UTC | EDGAR |
| 10-Q | 0001175454-26-000032 | Mar 31, 2026 | May 8, 2026 | May 8, 2026 12:41 UTC | EDGAR |
| 8-K | 0001175454-26-000029 | May 7, 2026 | May 7, 2026 | May 7, 2026 20:14 UTC | EDGAR |
| 8-K | 0001175454-26-000027 | Apr 27, 2026 | Apr 27, 2026 | Apr 27, 2026 12:33 UTC | EDGAR |
| 10-K | 0001175454-26-000018 | Dec 31, 2025 | Feb 27, 2026 | Feb 27, 2026 01:28 UTC | EDGAR |
| 8-K | 0001175454-26-000015 | Feb 26, 2026 | Feb 26, 2026 | Feb 26, 2026 22:26 UTC | EDGAR |
Direct links to SEC EDGAR. CPAY has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Cash Provided by (Used in) Operating Activities·Q1 2023
Major restatementwas$327.7M
Revised up in a 10-Q. Any P/OCF built on the original was 62.7% too high.
Net Cash Provided by (Used in) Operating Activities·Q3 2023
Major restatementwas$903.9M
Revised up in a 10-Q. Any P/OCF built on the original was 34.7% too high.
Net Cash Provided by (Used in) Operating Activities·Q1 2017
Major restatementwas$54.2M
Revised up in a 10-Q. Any P/OCF built on the original was 26.2% too high.
Net Cash Provided by (Used in) Operating Activities·Q2 2023
Major restatementwas$826.7M
Revised up in a 10-Q. Any P/OCF built on the original was 24.8% too high.
Net Cash Provided by (Used in) Operating Activities·Q2 2017
Major restatementwas$179M
Revised up in a 10-Q. Any P/OCF built on the original was 13.8% too high.
Stockholders' Equity Attributable to Parent·As of Dec 31, 2014
Notable restatementwas$2.8B
Revised down in a 10-K.
CPAY is not the only one.
See every restatement we've found across the market — or get an alert the next time CPAY revises a number.
Restatements are detected by comparing every vintage of a fact across all of CORPAY, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CPAY's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling CORPAY, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CPAY yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CPAY and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $3.76B |
| $3.43B |
| $2.83B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | $1.99B | $1.79B | $1.66B | $1.45B | $1.24B |
|---|
| Net Income | $1.07B | $1.00B | $0.98B | $0.95B | $0.84B |
|---|
| EPS (Diluted) | $15.03 | $13.97 | $13.20 | $12.42 | $9.99 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $26.41B | $17.96B | $15.48B | $14.09B | $13.40B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $3.93B | $3.15B | $3.28B | $2.54B | $2.87B |
| Cash & Equivalents | $2.41B | $4.46B | $1.39B | $2.29B | $2.25B |
| Total Debt | — | — | — | $7.04B | $5.98B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.50B | $1.94B | $2.10B | $0.75B | $1.20B |
| Capital Expenditures | $0.20B | $0.18B | $0.15B | $0.15B | $0.11B |
| Free Cash Flow | $1.30B | $1.77B | $1.95B | $0.60B | $1.09B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% |
| Net Margin | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% |
| Return on Equity | 30.3% | 31.2% | 33.7% | 35.3% | 27.0% |
| Return on Assets | 4.8% | 6.0% | 6.6% | 6.9% | 6.8% |
| Debt / Equity | 3.40× | 3.42× | 2.70× | 2.78× | 2.09× |
